Abstract:Vitamin D has an immunomodulatory effect on both innate and adaptive immune responses. Vitamin D has been reported to induce differentiation of monocytes into macrophages, inhibit maturation and differentiation of dendritic cells, and suppress adaptive immunity. Although there are some in vitro studies which showed that vitamin D suppressed Natural Killer (NK) cell activity and IFN‐γ secretion, little is known about the in vivo effect of vitamin D on NK cell functions. In this study, we investigated the in vivo effect of vitamin D on NK cell functions by measuring NK activity, cytokine secretion, activating receptor expression, and degranulation capacity in mice fed control or high‐fat diets containing different levels of vitamin D. Five week‐old C57BL/6 mice were divided into 6 groups by fat amount (10% or 45% kcal fat, CD or HFD) and vitamin D content (50, 1000, or 10000 IU/kg of diet, DD, DC, or DS), then fed diets for 12 weeks. NK cell activity was assessed using radioisotope 51 Cr release assay against YAC‐1 target cells. Splenocyte subpopulation was measured by flow cytometry (FACS) analysis. Intracellular expression of IFN‐γ by NK cell, CD4 T cell, and CD8 T cell and proportions of NK cells and CD8 T cells expressing NKG2D and CD107a were determined by FACS analysis upon stimulation of splenocytes with PMA (50 ng/mL)/ionomycin (0.5 μM) for 4 hours. NK activity was significantly higher in NDDS group than HFDDS group at effector to target (E:T) ratios of 100:1, 50:1, and 12.5:1. NDDS group showed significantly higher NK activity compared with NDDD and NDDC groups at E:T ratios of 100:1 and 50:1, whereas there was no significant difference in NK activity among HFDDD, HFDDC, and HFDDS groups. Splenic CD11b‐ NK cell population was significantly higher in NDDS group than HFDDS group, while splenic CD11b+ NK cell population tended to be higher in NDDS group compared with HFDDS group ( p =0.057). Percentage of splenic NKT cell was significantly higher in NDDS group than HFDDS group. There were significant differences in the splenic population of CD4 T cell, CD8 T cell, and B cell between ND and HFD groups ( p =0.042, p =0.001, p <0.001). Intracellular expression of IFN‐γ and surface expressions of NKG2D, and CD107a in NK cells were not affected by the different levels of vitamin D. However, there were significantly higher surface expressions of CD107a by CD8 T cells in NDDD group compared with NDDS group. In conclusion, vitamin D supplementation enhanced splenic NK activity in control mice, whereas this effect of vitamin D was not observed in high‐fat diet‐induced obese mice. Alternation in splenic NK cell population might have partially contributed to increased NK activity by vitamin D supplementation. Support or Funding Information Supported by the grant from the National Research Foundation (NRF) of Korea (NRF‐2015R1D1A1A01059679).

Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy

Dietary vitamin D 3 supplementation enhances splenic NK cell activity in healthy and diabetic male mice

Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway

Effect of Vitamin D Supplementation on Glycemic Control in Newly Diagnosed Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program

Effects of Vitamin D3 Supplementation Combined with Standardized Hypoglycemic Regimen on Islet Β Cell Function and Macrovascular Complications in Newly Diagnosed Type 2 Diabetes Mellitus

Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial

The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study

Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial

Effects of Active Vitamin D on Insulin Resistance and Islet Β-Cell Function in Non-Diabetic Chronic Kidney Disease Patients: a Randomized Controlled Study

Effect of Chromium-Enriched Yeast on Fasting Plasma Glucose, Glycated Haemoglobin and Serum Lipid Levels in Patients with Type 2 Diabetes Mellitus Treated with Insulin

Effects of vitamin D supplementation on glucose and lipid metabolism in patients with type 2 diabetes mellitus and risk factors for insulin resistance

The effect of vitamin D therapy on inflammatory markers in patients with type 2 diabetes mellitus and diabetic peripheral polyneuropathy

Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study

Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes

Effect of oral vitamin D supplementation on glycemic control in patients with type 2 diabetes mellitus with coexisting hypovitaminosis D: A parellel group placebo controlled randomized controlled pilot study

Differential Effect of Vitamin D Supplementation on Natural Killer Cell Activity in Normal and Obese Mice

Effects of D3K2 With Periodontal Therapy in Diabetes Mellitus and Stage I‐II Periodontitis Patients

High Doses of Vitamin D and Specific Metabolic Parameters in Type 2 Diabetes Patients: Systematic Review

Effects of Vitamin D Supplementation on Glucose and Insulin Homeostasis and Incident Diabetes among Nondiabetic Adults: A Meta-Analysis of Randomized Controlled Trials

Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial